Eti Kovalevski-Ishai

This inventor holds 17 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Vascular Biogenics Ltd., Other. Active years: 2009-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eti Kovalevski-Ishai. Retrieved from https://idiyas.com/inventor/eti-kovalevski-ishai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 2)

% Patents Active = 29.4

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 204(Granted Patents)

Company Filing History:

16 out of 46

Vascular Biogenics Ltd.

patents

1 out of 834,513

Other

patents

Years Active: 2009-2018

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9968622 - High-purity phospholipids (2018-05-15),

2. 9566288 - High-purity phospholipids (2017-02-14),

3. 9206206 - Oxidized lipid compounds and uses thereof (2015-12-08),

4. 9006217 - High-purity phospholipids (2015-04-14),

5. 8999960 - Oxidized thiophospholipid compounds and uses thereof (2015-04-07),

6. 8802875 - Process for the preparation of oxidized phospholipids (2014-08-12),

7. 8759557 - Process for the preparation of oxidized phospholipids (2014-06-24),

8. 8569529 - High-purity phospholipids (2013-10-29),

9. 8563534 - Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis (2013-10-22),

10. 8501715 - Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders (2013-08-06),

11. 8158611 - Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis (2012-04-17),

12. 8124800 - Process for the preparation of oxidized phospholipids (2012-02-28),

13. 7973023 - Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders (2011-07-05),

14. 7902176 - Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders (2011-03-08),

15. 7893291 - Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis (2011-02-22),

Title: Innovations of Eti Kovalevski-Ishai

Introduction

Eti Kovalevski-Ishai is a prominent inventor based in Netania, Israel. He has made significant contributions to the field of phospholipid synthesis, holding a total of 17 patents. His work focuses on developing novel synthetic routes that are highly applicable for industrial preparation of therapeutically beneficial oxidized phospholipids.

Latest Patents

Among his latest patents, Eti has disclosed methods for efficiently preparing compounds with a glycerolic backbone and one or more oxidized moieties attached to it. These methods are devoid of column chromatography, which enhances their industrial applicability. Additionally, he has introduced novel methods for incorporating phosphorus-containing moieties, such as phosphate moieties, into these compounds. One of his notable inventions is the substantially pure 1-hexadecyl-2-(4'-carboxy)butyl-sn-glycero-3-phosphocholine (CI-201).

Career Highlights

Eti has worked with Vascular Biogenics Ltd., where he has further honed his expertise in the field. His innovative approaches have positioned him as a key figure in the development of phospholipid-based therapies.

Collaborations

Throughout his career, Eti has collaborated with notable professionals, including Gideon Halperin and Niva Yacov, who is a distinguished woman in the field.

Conclusion

Eti Kovalevski-Ishai's contributions to the field of phospholipid synthesis are noteworthy, and his innovative patents continue to influence therapeutic applications. His work exemplifies the importance of innovation in advancing medical science.

Profile summary based on public USPTO records.